Production (Stage)
Atai Life Sciences N.V.
ATAI
$2.32
$0.010.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -148.99M | -149.27M | -128.60M | -58.07M | -33.80M |
| Total Depreciation and Amortization | 606.00K | 473.00K | 349.00K | 340.00K | 337.00K |
| Total Amortization of Deferred Charges | 566.00K | 515.00K | 426.00K | 394.00K | 387.00K |
| Total Other Non-Cash Items | 76.03M | 75.04M | 50.25M | -22.70M | -51.30M |
| Change in Net Operating Assets | -5.92M | -9.20M | -2.53M | 844.00K | -1.21M |
| Cash from Operations | -77.71M | -82.44M | -80.10M | -79.19M | -85.58M |
| Capital Expenditure | -1.02M | -6.00K | -8.00K | -8.00K | 21.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 359.00K | 359.00K | 480.00K | 0.00 | 0.00 |
| Divestitures | -- | -- | -443.00K | -443.00K | -443.00K |
| Other Investing Activities | 37.35M | 58.82M | 51.76M | -19.09M | -57.42M |
| Cash from Investing | 36.69M | 59.17M | 51.79M | -19.54M | -57.84M |
| Total Debt Issued | 5.00M | 5.00M | 5.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 60.70M | 535.00K | 400.00K | 345.00K | 19.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -725.00K | -161.00K | -8.64M | -8.48M | -8.58M |
| Cash from Financing | 64.98M | 5.37M | -3.24M | -8.14M | -8.56M |
| Foreign Exchange rate Adjustments | 458.00K | 362.00K | 27.00K | 108.00K | -34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Net Change in Cash | 24.42M | -17.53M | -31.53M | -106.76M | -152.02M |